{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:25:54Z","timestamp":1789053954191,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jjcc.2025.09.005","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T22:13:02Z","timestamp":1758060782000},"page":"340-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early outcomes in patients undergoing heart re-transplantation in the era of HCV-viremic donors"],"prefix":"10.1016","volume":"87","author":[{"given":"Matylda","family":"Mazur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Carmona Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J.","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2025.09.005_bb0005","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.15585\/mmwr.mm6914a2","article-title":"Vital signs: newly reported acute and chronic hepatitis C cases - United States, 2009-2018","volume":"69","author":"Ryerson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0015","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.healun.2019.06.023","article-title":"Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era","volume":"38","author":"Madan","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.xjon.2022.10.007","article-title":"Trends and three-year outcomes of hepatitis C virus\u2013viremic donor heart transplant for hepatitis C virus\u2013seronegative recipients","volume":"12","author":"Ruck","year":"2022","journal-title":"JTCVS Open"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.athoracsur.2022.11.002","article-title":"Outcomes of over 1000 heart transplants using hepatitis C\u2013positive donors in the modern era","volume":"115","author":"Kwon","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014495","article-title":"Outcomes of adult heart transplantation using hepatitis C\u2013positive donors","volume":"9","author":"Kilic","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0035","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/j.jtcvs.2020.09.044","article-title":"Trends in the use of hepatitis C viremic donor hearts","volume":"163","author":"Li","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0040","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.healun.2019.08.019","article-title":"Outcomes of heart transplantation from hepatitis C virus-positive donors","volume":"38","author":"Aslam","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0045","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.healun.2018.01.1293","article-title":"Early outcomes using hepatitis C\u2013positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies","volume":"37","author":"Schlendorf","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0050","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.healun.2018.06.012","article-title":"Cardiac transplantation from non-viremic hepatitis C donors","volume":"37","author":"Patel","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac550","article-title":"A pilot trial for prevention of hepatitis C virus transmission from donor to organ transplant recipient with short-course glecaprevir\/pibrentasvir","volume":"9","author":"Ramirez-Sanchez","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s40472-019-00257-y","article-title":"Heart retransplantation: candidacy, outcomes, and management","volume":"7","author":"Barghash","year":"2020","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0065","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/j.1600-6143.2007.01902.x","article-title":"Heart retransplantation","volume":"7","author":"Johnson","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0070","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.healun.2020.03.004","article-title":"Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: an ISHLT expert consensus statement","volume":"39","author":"Aslam","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0075","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.healun.2019.07.001","article-title":"Outcomes in patients undergoing cardiac retransplantation: a propensity matched cohort analysis of the UNOS Registry","volume":"38","author":"Miller","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jtcvs.2019.01.135","article-title":"Outcomes of bridge to cardiac retransplantation in the contemporary mechanical circulatory support era","volume":"158","author":"Sanchez","year":"2019","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0085","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.jtcvs.2014.02.013","article-title":"Preoperative risk factors predict survival following cardiac retransplantation: analysis of the United Network for Organ Sharing database","volume":"147","author":"Belli","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.recesp.2021.06.010","article-title":"Results of heart retransplantation: subanalysis of the Spanish Heart Transplant Registry","volume":"75","author":"Salterain-Gonz\u00e1lez","year":"2022","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0095","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.amjsurg.2021.09.005","article-title":"Access to hepatitis C direct-acting antiviral therapy in hepatitis C-positive donor to hepatitis C-negative recipient solid-organ transplantation in a real-world setting","volume":"223","author":"Edmonds","year":"2022","journal-title":"Am J Surg"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.healun.2021.09.002","article-title":"Cost-effectiveness and system-wide impact of using hepatitis C-viremic donors for heart transplant","volume":"41","author":"Wayda","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/ajt.16245","article-title":"Cost-effectiveness of using hepatitis C viremic hearts for transplantation into HCV-negative recipients","volume":"21","author":"Logan","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0110","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/TP.0000000000004378","article-title":"The cost-effectiveness of transplanting hearts from hepatitis C-infected donors into uninfected recipients","volume":"107","author":"Woolley","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0115","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.healun.2019.08.010","article-title":"The impact of using hepatitis C virus nucleic acid test-positive donor hearts on heart transplant waitlist time and transplant rate","volume":"38","author":"Gernhofer","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15294","article-title":"Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors","volume":"38","author":"Kadosh","year":"2024","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0125","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.healun.2019.07.001","article-title":"Outcomes in patients undergoing cardiac retransplantation: a propensity matched cohort analysis of the UNOS Registry","volume":"38","author":"Miller","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0130","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/jama.296.15.1843","article-title":"Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients","volume":"296","author":"Gasink","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1053-2498(03)00148-7","article-title":"Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation","volume":"23","author":"Haji","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cardfail.2021.07.007","article-title":"HCV-positive allograft use in heart transplantation is associated with increased access to overdose donors and reduced waitlist mortality without compromising outcomes","volume":"28","author":"Altshuler","year":"2022","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.xjon.2022.10.007","article-title":"Trends and three-year outcomes of hepatitis C virus-viremic donor heart transplant for hepatitis C virus-seronegative recipients","volume":"12","author":"Ruck","year":"2022","journal-title":"JTCVS Open"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0150","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"EASL clinical practice guidelines: management of hepatitis C virus infection","volume":"55","author":"European Association for the Study of the Liver","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0155","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MAT.0000000000001034","article-title":"Trends in renal function among heart transplant recipients of donor-derived hepatitis C virus","volume":"66","author":"Zalawadiya","year":"2020","journal-title":"ASAIO J"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0160","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00007890-199901270-00015","article-title":"Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years","volume":"67","author":"Younossi","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/v15081702","article-title":"Long-term impact of direct-acting antivirals on liver fibrosis and survival in HCV-infected liver transplant recipients","volume":"15","author":"Gambato","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0170","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.athoracsur.2019.03.076","article-title":"Impact of the opioid epidemic on heart transplantation: donor characteristics and organ discard","volume":"108","author":"Phillips","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"25","key":"10.1016\/j.jjcc.2025.09.005_bb0175","article-title":"Similar goals, divergent paths: exploring approaches to hepatitis C treatment protocols in heart transplantation","volume":"S1071-9164","author":"Rao","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jjcc.2025.09.005_bb0180","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.healun.2022.01.010","article-title":"Clinical outcomes of heart transplantation using hepatitis C\u2013viremic donors: a systematic review with meta-analysis","volume":"41","author":"Villegas-Galaviz","year":"2022","journal-title":"J Heart Lung Transplant"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725002357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725002357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:20:52Z","timestamp":1775006452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508725002357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0914508725002357"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.09.005","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early outcomes in patients undergoing heart re-transplantation in the era of HCV-viremic donors","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese College of Cardiology. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}